Skip to main content

Illumina Inc. (ILMN) Stock

Illumina Inc. Stock Details, Movements and Public Alerts

Stock Details

Illumina Inc. (ILMN), a prominent company in the life sciences sector within the laboratory analytical instruments industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $99.25. Over the past 52 weeks, it has ranged between $68.70 and $156.66. This places the current price at 63.4% of its 52-week high and 44.5% above its 52-week low. Recent trading volume was recorded at 7. The International Securities Identification Number (ISIN) for this stock is US4523271090.

Market Cap

$15.01B

52-Week High

$156.66

-36.65% from high

52-Week Low

$68.70

+44.47% from low

Avg Daily Volume

7

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

22.32

PEG Ratio

0.62

Potentially undervalued

Price to Book

6.34

EV/EBITDA

51.88

EPS (TTM)

-$6.08

Price to Sales

3.46

Beta

1.33

Similar volatility to market

How is ILMN valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is ILMN's risk profile compared to the market?
With a beta of 1.33, Illumina Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 6.34 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-22.30%

Operating Margin

17.70%

Return on Equity

-23.80%

Return on Assets

4.96%

Revenue Growth (YoY)

-3.30%

Earnings Growth (YoY)

-96.50%

How profitable and efficient is ILMN's business model?
Illumina Inc. achieves a profit margin of -22.30%, meaning it retains $-22.30 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 17.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -23.80% and ROA at 4.96%, the company achieves moderate returns on invested capital.
What are ILMN's recent growth trends?
Illumina Inc.'s revenue declined by 3.30% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 96.50% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against LABORATORY ANALYTICAL INSTRUMENTS industry averages for proper context.

Company Size & Market

Shares Outstanding

158.30M

Book Value/Share

$14.89

Asset Type

Common Stock

What is ILMN's market capitalization and position?
Illumina Inc. has a market capitalization of $15.01B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 158.30M shares outstanding, the company's ownership is relatively concentrated. As a participant in the LABORATORY ANALYTICAL INSTRUMENTS industry, it competes with other firms in this sector.
How does ILMN's price compare to its book value?
Illumina Inc.'s book value per share is $14.89, while the current stock price is $99.25, resulting in a price-to-book (P/B) ratio of 6.67. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$108.88

9.70% upside potential

Analyst Recommendations

Strong Buy

5

Buy

7

Hold

11

Sell

0

Strong Sell

2

How reliable are analyst predictions for ILMN?
25 analysts cover ILMN with 48% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $108.88 implies 9.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on ILMN?
Current analyst recommendations:5 Strong Buy, 7 Buy, 11 Hold, 02 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 02:11 AM

Technical Indicators

What does ILMN's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret ILMN's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for ILMN and get notified when the price changes.

Stay Ahead of the Market with Illumina Inc. Alerts

Set up price alerts for Illumina Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.